Lonza

0QNO.L | LSE | 0 Urmăritori

CHF 562.20

+0.32%

CHF 1.80

Urmărește

Overview Metrics Financials

Fair Price

PEA 671.73

Overvalued by 6.5%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

Profile

Lonza Group AG is a Swiss global company headquartered in Basel. It specializes in providing a wide range of products and services in the biotechnology and pharmaceutical industries. The company offers a broad portfolio of products including active pharmaceutical ingredients, biological and chemical raw materials, diagnostic and therapeutic tools, as well as development and manufacturing services. Lonza is known for its expertise in the development and manufacturing of biotechnology products, including biopharmaceuticals, vaccines, cell therapies, and genetic engineering. The company has a global presence and is considered one of the leaders in the biotechnology and pharmaceutical industries. Shares of Lonza Group AG are publicly traded on the Swiss stock exchange.

Feed

There are no posts to show right now.

Lonza

Fair Price

Profile

Feed

Logare în Bulios

Creează-ți profilul pe Bulios

De ce Bulios?